Disease Markers / 2020 / Article / Tab 3 / Review Article
The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis Table 3 Subgroup analysis and metaregression of the studies reporting the prognostic role of F-NLR score in DFS/PFS.
Stratified study No. of studies Pooled HR (95% CI) Heterogeneity Metaregression (%) valueTau2 Adj (%) valueCancer type 0.13 -35.24 0.9 Digestive system 3 1.875 (1.133-3.102) 76.6 0.01 NSCLC 2 1.32 (1.076-1.619) 68.1 0.08 Other type 1 2.49 (1.618-3.832) — — Publication year 0.04 63.11 0.1 ≥2017 5 1.471 (1.22-1.773) 64.9 0.02 <2017 1 3.26 (1.909-5.567) — — Sample size 0.01 93.11 0.03 3 2.383 (1.659-3.422) 37.3 0.2 3 1.334 (1.169-1.523) 39 0.19 Country 0.07 25.86 0.34 China 4 1.497 (1.182-1.896) 71.6 <0.01 Japan 1 1.65 (0.969-2.808) — — Italy 1 2.49 (1.618-3.832) — — Analysis type 0.07 21.85 0.21 Multivariate 2 1.32 (1.076-1.619) 68.1 0.08 Univariate 4 2.005 (1.327-3.031) 75.6 <0.01 Gender (female, %) 0.06 33.39 0.25 >31 4 1.46 (1.189-1.793) 72.6 0.01 ≤31 2 2.318 (1.189-4.517) 68 0.08 Age (year) 0.06 30.42 0.16 >60 3 1.278 (1.12-1.459) 82.9 <0.01 ≤60 3 2.181 (1.304-3.646) 5.8 0.34